SHA:603456 Market Cap

SHA:603456 has a market cap or net worth of 15.47 billion as of February 23, 2026. Its market cap has increased by 32.15% in one year.

Market Cap

15.47B

Enterprise Value

12.97B

Revenue

5.36B

Ranking

n/a

PE Ratio

21.44

Stock Price

17.70

Market Cap Chart

Since October 10, 2014, SHA:603456's market cap has increased from 4.62B to 15.47B, an increase of 235.16%. That is a compound annual growth rate of 11.24%.

Market Cap History

Date	Market Cap	% Change
Feb 13, 2026	15.47B	-1.96%
Dec 31, 2025	15.78B	28.87%
Dec 31, 2024	12.25B	-43.76%
Dec 29, 2023	21.78B	-38.48%
Dec 30, 2022	35.40B	-24.43%
Dec 31, 2021	46.84B	62.49%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hybio Pharmaceutical	16.16B
Guangdong Zhongsheng Pharmaceutical	16.11B
Shenzhen Hepalink Pharmaceutical Group	16.08B
Wedge Industrial	15.89B
Nanjing King-Friend Biochemical Pharmaceutical	15.88B
Guobang Pharma	15.79B
China Resources Jiangzhong Pharmaceutical Co.,Ltd	15.69B
Zhejiang Medicine	15.19B

Market Cap Rankings